Cargando…

Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice

BACKGROUND: The COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Jamie J., Botkai, Adam, Marson, Ella J., Evison, Felicity, Atia, Jolene, Wang, Jingyi, Gallier, Suzy, Speakman, John, Pankhurst, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438269/
https://www.ncbi.nlm.nih.gov/pubmed/32827587
http://dx.doi.org/10.1016/j.resuscitation.2020.08.006
_version_ 1783572764092792832
author Coleman, Jamie J.
Botkai, Adam
Marson, Ella J.
Evison, Felicity
Atia, Jolene
Wang, Jingyi
Gallier, Suzy
Speakman, John
Pankhurst, Tanya
author_facet Coleman, Jamie J.
Botkai, Adam
Marson, Ella J.
Evison, Felicity
Atia, Jolene
Wang, Jingyi
Gallier, Suzy
Speakman, John
Pankhurst, Tanya
author_sort Coleman, Jamie J.
collection PubMed
description BACKGROUND: The COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure complicates the benefit/harm balance of CPR. METHODS: The study is based at a large teaching hospital in the United Kingdom where all DNACPR decisions are documented on an electronic healthcare record (EHR). Data from all DNACPR/TEAL status forms between 1st January 2017 and 30th April 2020 were collected and analysed. We compared patterns of decision making and rates of form completion during the 2-month peak pandemic phase to an analogous period during 2019. RESULTS: A total of 16,007 forms were completed during the study period with a marked increase in form completion during the COVID-19 pandemic. Patients with a form completed were on average younger and had fewer co-morbidities during the COVID-19 period than in March-April 2019. Several questions on the DNACPR/TEAL forms were answered significantly differently with increases in patients being identified as suitable for CPR (23.8% versus 9.05%; p < 0.001) and full active treatment (30.5% versus 26.1%; p = 0.028). Whilst proportions of discussions that involved the patient remained similar during COVID-19 (95.8% versus 95.6%; p = 0.871), fewer discussions took place with relatives (50.6% versus 75.4%; p < 0.001). CONCLUSION: During the COVID-19 pandemic, the emphasis on senior decision making and conversations around ceilings of treatment appears to have changed practice, with a higher proportion of patients having DNACPR/TEAL status documented. Understanding patient preferences around life-sustaining treatment versus comfort care is part of holistic practice and supports shared decision making. It is unclear whether these attitudinal changes will be sustained after COVID-19 admissions decrease.
format Online
Article
Text
id pubmed-7438269
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74382692020-08-20 Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice Coleman, Jamie J. Botkai, Adam Marson, Ella J. Evison, Felicity Atia, Jolene Wang, Jingyi Gallier, Suzy Speakman, John Pankhurst, Tanya Resuscitation Clinical Paper BACKGROUND: The COVID-19 pandemic has introduced further challenges into Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decisions. Existing evidence suggests success rates for CPR in COVID-19 patients is low and the risk to healthcare professionals from this aerosol-generating procedure complicates the benefit/harm balance of CPR. METHODS: The study is based at a large teaching hospital in the United Kingdom where all DNACPR decisions are documented on an electronic healthcare record (EHR). Data from all DNACPR/TEAL status forms between 1st January 2017 and 30th April 2020 were collected and analysed. We compared patterns of decision making and rates of form completion during the 2-month peak pandemic phase to an analogous period during 2019. RESULTS: A total of 16,007 forms were completed during the study period with a marked increase in form completion during the COVID-19 pandemic. Patients with a form completed were on average younger and had fewer co-morbidities during the COVID-19 period than in March-April 2019. Several questions on the DNACPR/TEAL forms were answered significantly differently with increases in patients being identified as suitable for CPR (23.8% versus 9.05%; p < 0.001) and full active treatment (30.5% versus 26.1%; p = 0.028). Whilst proportions of discussions that involved the patient remained similar during COVID-19 (95.8% versus 95.6%; p = 0.871), fewer discussions took place with relatives (50.6% versus 75.4%; p < 0.001). CONCLUSION: During the COVID-19 pandemic, the emphasis on senior decision making and conversations around ceilings of treatment appears to have changed practice, with a higher proportion of patients having DNACPR/TEAL status documented. Understanding patient preferences around life-sustaining treatment versus comfort care is part of holistic practice and supports shared decision making. It is unclear whether these attitudinal changes will be sustained after COVID-19 admissions decrease. Published by Elsevier B.V. 2020-10 2020-08-20 /pmc/articles/PMC7438269/ /pubmed/32827587 http://dx.doi.org/10.1016/j.resuscitation.2020.08.006 Text en Crown Copyright © 2020 Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Paper
Coleman, Jamie J.
Botkai, Adam
Marson, Ella J.
Evison, Felicity
Atia, Jolene
Wang, Jingyi
Gallier, Suzy
Speakman, John
Pankhurst, Tanya
Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice
title Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice
title_full Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice
title_fullStr Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice
title_full_unstemmed Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice
title_short Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice
title_sort bringing into focus treatment limitation and dnacpr decisions: how covid-19 has changed practice
topic Clinical Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438269/
https://www.ncbi.nlm.nih.gov/pubmed/32827587
http://dx.doi.org/10.1016/j.resuscitation.2020.08.006
work_keys_str_mv AT colemanjamiej bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT botkaiadam bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT marsonellaj bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT evisonfelicity bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT atiajolene bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT wangjingyi bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT galliersuzy bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT speakmanjohn bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice
AT pankhursttanya bringingintofocustreatmentlimitationanddnacprdecisionshowcovid19haschangedpractice